{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-07-22",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Completed",
      "city": "Indianapolis",
      "state": "IN",
      "country": "United States",
      "classification": "Class II",
      "openfda": {
        "application_number": [
          "BLA205747"
        ],
        "brand_name": [
          "HUMALOG"
        ],
        "generic_name": [
          "INSULIN LISPRO"
        ],
        "manufacturer_name": [
          "Eli Lilly and Company"
        ],
        "product_ndc": [
          "0002-7712",
          "0002-7510",
          "0002-7533",
          "0002-8799",
          "0002-7516",
          "0002-7714",
          "0002-8213",
          "0002-0800",
          "0002-8208"
        ],
        "product_type": [
          "HUMAN PRESCRIPTION DRUG"
        ],
        "route": [
          "SUBCUTANEOUS"
        ],
        "substance_name": [
          "INSULIN LISPRO"
        ],
        "rxcui": [
          "242120",
          "865098",
          "1652239",
          "1652242",
          "1652639",
          "1652640",
          "1652644",
          "1652646",
          "1926331",
          "1926332",
          "2621571",
          "2621572"
        ],
        "spl_id": [
          "d0a38a0f-9d29-44eb-bfd1-c83cbcba1008"
        ],
        "spl_set_id": [
          "c8ecbd7a-0e22-4fc7-a503-faa58c1b6f3f"
        ],
        "package_ndc": [
          "0002-7510-01",
          "0002-7510-17",
          "0002-7510-99",
          "0002-7533-01",
          "0002-8799-01",
          "0002-8799-59",
          "0002-8799-61",
          "0002-7516-01",
          "0002-7516-59",
          "0002-7516-99",
          "0002-7714-01",
          "0002-7714-59",
          "0002-7714-61",
          "0002-8213-01",
          "0002-8213-05",
          "0002-0800-01",
          "0002-7712-01",
          "0002-7712-27",
          "0002-7712-61",
          "0002-8208-01",
          "0002-8208-27"
        ],
        "is_original_packager": [
          true
        ],
        "nui": [
          "N0000004931",
          "N0000175453"
        ],
        "pharm_class_cs": [
          "Insulin [Chemical/Ingredient]"
        ],
        "pharm_class_epc": [
          "Insulin Analog [EPC]"
        ],
        "unii": [
          "059QF0KO0R",
          "GFX7QIS1II"
        ]
      },
      "product_type": "Drugs",
      "event_id": "94214",
      "recalling_firm": "Eli Lilly & Company",
      "address_1": "893 S Delaware St",
      "address_2": "",
      "postal_code": "46225-1782",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "E-Mail",
      "distribution_pattern": "Nationwide USA",
      "recall_number": "D-0445-2024",
      "product_description": "Sterile Diluent, HUMALOG U-100 (insulin lispro injection), HUMULIN R U-100 REGULAR (insulin human injection), Insulin Lispro Injection u-100, 10 mL, Use ONLY with Insulins listed on carton, Marketed by: Lilly USA, LLC, Indianapolis, IN 46285.  NDC: 0002-0800-01",
      "product_quantity": "700 vials",
      "reason_for_recall": "CGMP Deviations",
      "recall_initiation_date": "20240312",
      "center_classification_date": "20240417",
      "report_date": "20240424",
      "code_info": "Batch number: D608951C, exp 4/10/2025",
      "more_code_info": ""
    }
  ]
}